-
1
-
-
1242335471
-
The MRP-related and BCRP/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation
-
Haimeur A, Conseil G, Deeley RG, Cole SP. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 2004 5 : 21 53.
-
(2004)
Curr Drug Metab
, vol.5
, pp. 21-53
-
-
Haimeur, A.1
Conseil, G.2
Deeley, R.G.3
Cole, S.P.4
-
2
-
-
2142799057
-
Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy
-
Lockhart AC, Tirona RG, Kim RB. Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy. Mol Cancer Ther 2003 2 : 685 98.
-
(2003)
Mol Cancer Ther
, vol.2
, pp. 685-98
-
-
Lockhart, A.C.1
Tirona, R.G.2
Kim, R.B.3
-
3
-
-
0037988709
-
Pharmacogenomics of ABC transporters and its role in cancer chemotherapy
-
Sparreboom A, Danesi R, Ando Y, Chan J, Figg WD. Pharmacogenomics of ABC transporters and its role in cancer chemotherapy. Drug Resist Updat 2003 6 : 71 84.
-
(2003)
Drug Resist Updat
, vol.6
, pp. 71-84
-
-
Sparreboom, A.1
Danesi, R.2
Ando, Y.3
Chan, J.4
Figg, W.D.5
-
4
-
-
25844443754
-
Breast cancer resistance protein: Molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics
-
Sugimoto Y, Tsukahara S, Ishikawa E, Mitsuhashi J. Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics. Cancer Sci 2005 96 : 457 65.
-
(2005)
Cancer Sci
, vol.96
, pp. 457-65
-
-
Sugimoto, Y.1
Tsukahara, S.2
Ishikawa, E.3
Mitsuhashi, J.4
-
5
-
-
0001744641
-
Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2)
-
Allen JD, Schinkel AH. Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2). Mol Cancer Ther 2002 1 : 427 34.
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 427-34
-
-
Allen, J.D.1
Schinkel, A.H.2
-
6
-
-
0032404092
-
A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance
-
Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 1998 58 : 5337 9.
-
(1998)
Cancer Res
, vol.58
, pp. 5337-9
-
-
Allikmets, R.1
Schriml, L.M.2
Hutchinson, A.3
Romano-Spica, V.4
Dean, M.5
-
7
-
-
13044249156
-
A multidrug resistance transporter from human MCF-7 breast cancer cells
-
Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998 95 : 15665 70.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 15665-70
-
-
Doyle, L.A.1
Yang, W.2
Abruzzo, L.V.3
Krogmann, T.4
Gao, Y.5
Rishi, A.K.6
Ross, D.D.7
-
8
-
-
0035300476
-
Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure
-
Komatani H, Kotani H, Hara Y, Nakagawa R, Matsumoto M, Arakawa H, Nishimura S. Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure. Cancer Res 2001 61 : 2827 32.
-
(2001)
Cancer Res
, vol.61
, pp. 2827-32
-
-
Komatani, H.1
Kotani, H.2
Hara, Y.3
Nakagawa, R.4
Matsumoto, M.5
Arakawa, H.6
Nishimura, S.7
-
9
-
-
0034817098
-
Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells
-
Kawabata S, Oka M, Shiozawa K, Tsukamoto K, Nakatomi K, Soda H, Fukuda M, Ikegami Y, Sugahara K, Yamada Y, Kamihira S, Doyle LA, Ross DD, Kohno S. Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem Biophys Res Commun 2001 280 : 1216 23.
-
(2001)
Biochem Biophys Res Commun
, vol.280
, pp. 1216-23
-
-
Kawabata, S.1
Oka, M.2
Shiozawa, K.3
Tsukamoto, K.4
Nakatomi, K.5
Soda, H.6
Fukuda, M.7
Ikegami, Y.8
Sugahara, K.9
Yamada, Y.10
Kamihira, S.11
Doyle, L.A.12
Ross, D.D.13
Kohno, S.14
-
10
-
-
0036929837
-
ABCG2 confers resistance to indolocarbazole compounds by ATP-dependent transport
-
Nakagawa R, Hara Y, Arakawa H, Nishimura S, Komatani H. ABCG2 confers resistance to indolocarbazole compounds by ATP-dependent transport. Biochem Biophys Res Commun 2002 299 : 669 75.
-
(2002)
Biochem Biophys Res Commun
, vol.299
, pp. 669-75
-
-
Nakagawa, R.1
Hara, Y.2
Arakawa, H.3
Nishimura, S.4
Komatani, H.5
-
11
-
-
0036732010
-
Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance
-
Volk EL, Farley KM, Wu Y, Li F, Robey RW, Schneider E. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res 2002 62 : 5035 40.
-
(2002)
Cancer Res
, vol.62
, pp. 5035-40
-
-
Volk, E.L.1
Farley, K.M.2
Wu, Y.3
Li, F.4
Robey, R.W.5
Schneider, E.6
-
12
-
-
0037218382
-
Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors
-
Wang X, Furukawa T, Nitanda T, Okamoto M, Sugimoto Y, Akiyama S, Baba M. Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. Mol Pharmacol 2003 63 : 65 72.
-
(2003)
Mol Pharmacol
, vol.63
, pp. 65-72
-
-
Wang, X.1
Furukawa, T.2
Nitanda, T.3
Okamoto, M.4
Sugimoto, Y.5
Akiyama, S.6
Baba, M.7
-
13
-
-
4444383451
-
Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein
-
Wang X, Nitanda T, Shi M, Okamoto M, Furukawa T, Sugimoto Y, Akiyama S, Baba M. Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein. Biochem Pharmacol 2004 68 : 1363 70.
-
(2004)
Biochem Pharmacol
, vol.68
, pp. 1363-70
-
-
Wang, X.1
Nitanda, T.2
Shi, M.3
Okamoto, M.4
Furukawa, T.5
Sugimoto, Y.6
Akiyama, S.7
Baba, M.8
-
14
-
-
0036598543
-
C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance
-
Imai Y, Nakane M, Kage K, Tsukahara S, Ishikawa E, Tsuruo T, Miki Y, Sugimoto Y. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol Cancer Ther 2002 1 : 611 6.
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 611-6
-
-
Imai, Y.1
Nakane, M.2
Kage, K.3
Tsukahara, S.4
Ishikawa, E.5
Tsuruo, T.6
Miki, Y.7
Sugimoto, Y.8
-
15
-
-
1242319383
-
Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2
-
Mizuarai S, Aozasa N, Kotani H. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2. Int J Cancer 2004 109 : 238 46.
-
(2004)
Int J Cancer
, vol.109
, pp. 238-46
-
-
Mizuarai, S.1
Aozasa, N.2
Kotani, H.3
-
16
-
-
3042651340
-
Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype
-
Sparreboom A, Gelderblom H, Marsh S, Ahluwalia R, Obach R, Principe P, Twelves C, Verweij J, McLeod HL. Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype. Clin Pharmacol Ther 2004 76 : 38 44.
-
(2004)
Clin Pharmacol Ther
, vol.76
, pp. 38-44
-
-
Sparreboom, A.1
Gelderblom, H.2
Marsh, S.3
Ahluwalia, R.4
Obach, R.5
Principe, P.6
Twelves, C.7
Verweij, J.8
McLeod, H.L.9
-
17
-
-
33747884712
-
Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males
-
Zhang W, Yu BN, He YJ, Fan L, Li Q, Liu ZQ, Wang A, Liu YL, Tan ZR, Fen J, Huang YF, Zhou HH. Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. Clin Chim Acta 2006 373 : 99 103.
-
(2006)
Clin Chim Acta
, vol.373
, pp. 99-103
-
-
Zhang, W.1
Yu, B.N.2
He, Y.J.3
Fan, L.4
Li, Q.5
Liu, Z.Q.6
Wang, A.7
Liu, Y.L.8
Tan, Z.R.9
Fen, J.10
Huang, Y.F.11
Zhou, H.H.12
-
18
-
-
0032906981
-
Clinical pharmacokinetics of lamivudine
-
Johnson MA, Moore KH, Yuen GJ, Bye A, Pakes GE. Clinical pharmacokinetics of lamivudine. Clin Pharmacokinet 1999 36 : 41 66.
-
(1999)
Clin Pharmacokinet
, vol.36
, pp. 41-66
-
-
Johnson, M.A.1
Moore, K.H.2
Yuen, G.J.3
Bye, A.4
Pakes, G.E.5
-
19
-
-
35248839749
-
-
Epivir Prescribing Information. Available at URL. Last accessed
-
Epivir Prescribing Information. Available at URL. http://us.gsk.com/ products/assets/us_epivir.pdf Last accessed 2 January 2005.
-
(2005)
-
-
-
21
-
-
0036592531
-
Update on the management of chronic hepatitis B
-
Davis GL. Update on the management of chronic hepatitis B. Rev Gastroenterol Disord 2002 2 : 106 15.
-
(2002)
Rev Gastroenterol Disord
, vol.2
, pp. 106-15
-
-
Davis, G.L.1
-
22
-
-
0035949821
-
High-performance liquid chromatographic assay for the determination of 2′-deoxy-3′-thiacytidine (lamivudine) in human plasma
-
Zheng JJ, Wu ST, Emm TA. High-performance liquid chromatographic assay for the determination of 2′-deoxy-3′-thiacytidine (lamivudine) in human plasma. J Chromatogr B Biomed Sci Appl 2001 761 : 195 201.
-
(2001)
J Chromatogr B Biomed Sci Appl
, vol.761
, pp. 195-201
-
-
Zheng, J.J.1
Wu, S.T.2
Emm, T.A.3
-
23
-
-
19944399722
-
Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta
-
Kobayashi D, Ieiri I, Hirota T, Takane H, Maegawa S, Kigawa J, Suzuki H, Nanba E, Oshimura M, Terakawa N, Otsubo K, Mine K, Sugiyama Y. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab Dispos 2005 33 : 94 101.
-
(2005)
Drug Metab Dispos
, vol.33
, pp. 94-101
-
-
Kobayashi, D.1
Ieiri, I.2
Hirota, T.3
Takane, H.4
Maegawa, S.5
Kigawa, J.6
Suzuki, H.7
Nanba, E.8
Oshimura, M.9
Terakawa, N.10
Otsubo, K.11
Mine, K.12
Sugiyama, Y.13
-
24
-
-
0035125214
-
Uptake properties of lamivudine (3TC) by a continuous renal epithelial cell line
-
Leung S, Bendayan R. Uptake properties of lamivudine (3TC) by a continuous renal epithelial cell line. Can J Physiol Pharmacol 2001 79 : 59 66.
-
(2001)
Can J Physiol Pharmacol
, vol.79
, pp. 59-66
-
-
Leung, S.1
Bendayan, R.2
-
25
-
-
0036162333
-
Uptake of lamivudine by rat renal brush border membrane vesicles
-
Takubo T, Kato T, Kinami J, Hanada K, Ogata H. Uptake of lamivudine by rat renal brush border membrane vesicles. J Pharm Pharmacol 2002 54 : 111 7.
-
(2002)
J Pharm Pharmacol
, vol.54
, pp. 111-7
-
-
Takubo, T.1
Kato, T.2
Kinami, J.3
Hanada, K.4
Ogata, H.5
-
26
-
-
0033849375
-
Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs
-
Wada S, Tsuda M, Sekine T, Cha SH, Kimura M, Kanai Y, Endou H. Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. J Pharmacol Exp Ther 2000 294 : 844 9.
-
(2000)
J Pharmacol Exp Ther
, vol.294
, pp. 844-9
-
-
Wada, S.1
Tsuda, M.2
Sekine, T.3
Cha, S.H.4
Kimura, M.5
Kanai, Y.6
Endou, H.7
-
27
-
-
0032879904
-
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
-
Schuetz JD, Connelly MC, Sun D, Paibir SG, Flynn PM, Srinivas RV, Kumar A, Fridland A. MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat Med 1999 5 : 1048 51.
-
(1999)
Nat Med
, vol.5
, pp. 1048-51
-
-
Schuetz, J.D.1
Connelly, M.C.2
Sun, D.3
Paibir, S.G.4
Flynn, P.M.5
Srinivas, R.V.6
Kumar, A.7
Fridland, A.8
-
28
-
-
0037110745
-
Impaired 2′,3′-dideoxy-3′-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11
-
Turriziani O, Schuetz JD, Focher F, Scagnolari C, Sampath J, Adachi M, Bambacioni F, Riva E, Antonelli G. Impaired 2′,3′-dideoxy-3′- thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11. Biochem J 2002 368 : 325 32.
-
(2002)
Biochem J
, vol.368
, pp. 325-32
-
-
Turriziani, O.1
Schuetz, J.D.2
Focher, F.3
Scagnolari, C.4
Sampath, J.5
Adachi, M.6
Bambacioni, F.7
Riva, E.8
Antonelli, G.9
-
29
-
-
12944270590
-
Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs
-
Wijnholds J, Mol CA, van Deemter L, de Haas M, Scheffer GL, Baas F, Beijnen JH, Scheper RJ, Hatse S, De Clercq E, Balzarini J, Borst P. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci USA 2000 97 : 7476 81.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 7476-81
-
-
Wijnholds, J.1
Mol, C.A.2
Van Deemter, L.3
De Haas, M.4
Scheffer, G.L.5
Baas, F.6
Beijnen, J.H.7
Scheper, R.J.8
Hatse, S.9
De Clercq, E.10
Balzarini, J.11
Borst, P.12
-
30
-
-
0035834595
-
Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells
-
Nakatomi K, Yoshikawa M, Oka M, Ikegami Y, Hayasaka S, Sano K, Shiozawa K, Kawabata S, Soda H, Ishikawa T, Tanabe S, Kohno S. Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem Biophys Res Commun 2001 288 : 827 32.
-
(2001)
Biochem Biophys Res Commun
, vol.288
, pp. 827-32
-
-
Nakatomi, K.1
Yoshikawa, M.2
Oka, M.3
Ikegami, Y.4
Hayasaka, S.5
Sano, K.6
Shiozawa, K.7
Kawabata, S.8
Soda, H.9
Ishikawa, T.10
Tanabe, S.11
Kohno, S.12
-
31
-
-
0038265441
-
ABCG2 transports sulfated conjugates of steroids and xenobiotics
-
Suzuki M, Suzuki H, Sugimoto Y, Sugiyama Y. ABCG2 transports sulfated conjugates of steroids and xenobiotics. J Biol Chem 2003 278 : 22644 9.
-
(2003)
J Biol Chem
, vol.278
, pp. 22644-9
-
-
Suzuki, M.1
Suzuki, H.2
Sugimoto, Y.3
Sugiyama, Y.4
-
32
-
-
0141815941
-
Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter
-
Volk EL, Schneider E. Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Res 2003 63 : 5538 43.
-
(2003)
Cancer Res
, vol.63
, pp. 5538-43
-
-
Volk, E.L.1
Schneider, E.2
-
33
-
-
33745929357
-
Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: A pilot study
-
Anderson PL, Lamba J, Aquilante CL, Schuetz E, Fletcher CV. Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study. J Acquir Immune Defic Syndr 2006 42 : 441 9.
-
(2006)
J Acquir Immune Defic Syndr
, vol.42
, pp. 441-9
-
-
Anderson, P.L.1
Lamba, J.2
Aquilante, C.L.3
Schuetz, E.4
Fletcher, C.V.5
-
34
-
-
0342652467
-
Viral and cellular factors for resistance against antiretroviral agents
-
Groschel B, Cinatl J, Cinatl J Jr. Viral and cellular factors for resistance against antiretroviral agents. Intervirology 1997 40 : 400 7.
-
(1997)
Intervirology
, vol.40
, pp. 400-7
-
-
Groschel, B.1
Cinatl, J.2
Cinatl Jr., J.3
|